Skip to main content
. 2013 Apr 8;8(4):e60817. doi: 10.1371/journal.pone.0060817

Figure 8. Suppression of IL-6 and its pathways by minocycline in mice bearing ovarian tumors.

Figure 8

(A) IL-6 levels were determined by ELISA in the plasma of mice bearing i.p. OVCAR-3 tumors, 4 and 24 h post minocycline treatment (single dose 30 mg/kg; i.p.) (B) Tumors harvested at 4 and 24 h were examined by western blot analysis for the expression of IL-6, p-STAT3 (Tyr 705), MCL-1 and p-ERK1/2 protein. (*p<0.05, **p<0.01 and ***p<0.001 vs. control).